Inogen Inc (NASDAQ:INGN)
| Market Cap | $137.81M-25.1% |
| Revenue (ttm) | $339.11M-2.3% |
| Net Income | -$35.46M-39.7% |
| EPS | -$1.31-29.7% |
| Shares Out | 26.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 351,931 |
| Open | $5.40 |
| Previous Close | $5.42 |
| Day's Range | $5.25 - $5.67 |
| 52-Week Range | $5.04 - $7.67 |
| Beta | 1.49 |
| Analysts | Buy |
| Price Target | $26.00(+390.57%) |
| Earnings Date | Feb 25, 2027 |
About INGN
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Feb 25, 2027Earnings report
$INGN stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in INGN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by INGN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
INGN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
INGN Revenue by Segment or Geography
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New INGN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to INGN from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in INGN
| VTIVanguard Morningstar Total Stock Market ETF | $3.90M |
| IWMiShares Russell 2000 ETF | $3.51M |
| VXFVanguard Extended Market ETF | $1.86M |
| IWNiShares Russell 2000 Value ETF | $1.16M |
| VTWOVanguard Russell 2000 ETF | $996.92K |
| DFASDimensional - US Small Cap ETF | $892.30K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from INGN’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.61% |
| CVAR | ETF Opportunities Trust - Cultivar ETF | 0.33% |
| LNGR | Global X Aging Population ETF | 0.23% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.21% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.20% |
| BUSM | EA Series Trust - EA Bridgeway Ultra-Small Company Market ETF | 0.18% |
| DMRS | DeltaShares S&P 600 Managed Risk ETF | 0.15% |
| FSCC | Federated Hermes MDT Small Cap Core ETF | 0.14% |
| FSEV | Fidelity Enhanced Small Cap Value ETF | 0.14% |
| PQSV | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF | 0.13% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.07% |
| FEAC | Fidelity Covington Trust - Fidelity Enhanced U.S. All-Cap Equity ETF | 0.04% |
Weight is the stock’s share of each fund’s holdings.
